ST. LOUIS--(BUSINESS WIRE)--Aug. 22, 2005--RiverVest Venture Partners(R), a venture capital firm investing nationwide in emerging medical technology and biopharmaceutical companies, today announced that Gordon Foulkes, Ph.D., has joined the firm as a Venture Partner. Dr. Foulkes brings to RiverVest extensive operational experience in biopharmaceutical research and development. Prior to joining RiverVest, he headed research and development in three biotechnology companies where he helped raise $145 million in private and public offerings and secure more than $200 million in 15 corporate partnerships.
